Breast cancer screening in an era of personalized regimens: A conceptual model and National Cancer Institute initiative for risk‐based and preference‐based approaches at a population level
Open Access
Abstract
Breast cancer screening holds a prominent place in public health, health care delivery, policy, and women's health care decisions. Several factors are driving shifts in how population‐based breast cancer screening is approached, including advanced imaging technologies, health system performance measures, health care reform, concern for “overdiagnosis,” and improved understanding of risk. Maximizing benefits while minimizing the harms of screening requires moving from a “1‐size‐fits‐all” guideline paradigm to more personalized strategies. A refined conceptual model for breast cancer screening is needed to align women's risks and preferences with screening regimens. A conceptual model of personalized breast cancer screening is presented herein that emphasizes key domains and transitions throughout the screening process, as well as multilevel perspectives. The key domains of screening awareness, detection, diagnosis, and treatment and survivorship are conceptualized to function at the level of the patient, provider, facility, health care system, and population/policy arena. Personalized breast cancer screening can be assessed across these domains with both process and outcome measures. Identifying, evaluating, and monitoring process measures in screening is a focus of a National Cancer Institute initiative entitled PROSPR (Population‐based Research Optimizing Screening through Personalized Regimens), which will provide generalizable evidence for a risk‐based model of breast cancer screening, The model presented builds on prior breast cancer screening models and may serve to identify new measures to optimize benefits‐to‐harms tradeoffs in population‐based screening, which is a timely goal in the era of health care reform. Cancer 2014;120:2955–2964. © 2014 American Cancer Society.Keywords
Funding Information
- National Cancer Institute (U01CA163304)
- National Cancer Institute (U54CA163313-03)
- National Cancer Institute (U54CA163307-01)
- National Cancer Institute (U54CA163303-03)
This publication has 36 references indexed in Scilit:
- Long-Term Psychosocial Consequences of False-Positive Screening MammographyThe Annals of Family Medicine, 2013
- A Multilevel Research Perspective on Cancer Care Delivery: The Example of Follow-Up to An Abnormal MammogramCancer Epidemiology, Biomarkers & Prevention, 2012
- Introduction: Understanding and Influencing Multilevel Factors Across the Cancer Care ContinuumJournal of the National Cancer Institute Monographs, 2012
- Cost of Breast-Related Care in the Year Following False Positive Screening MammogramsMedical Care, 2010
- Data and trends in cancer screening in the United StatesCancer, 2010
- Evidence-Based Breast Cancer Prevention: The Importance of Individual RiskAnnals of Internal Medicine, 2009
- Estimates of overdiagnosis of invasive breast cancer associated with screening mammographyCancer Causes & Control, 2009
- Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancerBreast Cancer Research, 2005
- Application of Breast Cancer Risk Prediction Models in Clinical PracticeJournal of Clinical Oncology, 2003
- Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast ExaminationsNew England Journal of Medicine, 1998